Reproducing extracellular matrix adverse remodelling of non-ST myocardial infarction in a large animal model

[1]  Markus M. Hilscher,et al.  Metabolic reprogramming and membrane glycan remodeling as potential drivers of zebrafish heart regeneration , 2022, Communications biology.

[2]  T. Arinzeh,et al.  Biomaterials and Tissue Engineering Approaches using Glycosaminoglycans for Tissue Repair: Lessons Learned from the Native Extracellular Matrix. , 2022, Acta biomaterialia.

[3]  A. Varki,et al.  Discovery, classification, evolution and diversity of Siglecs. , 2022, Molecular aspects of medicine.

[4]  R. Spelat,et al.  Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction , 2022, Biomolecules.

[5]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[6]  X. Tan,et al.  N-glycan profiles of acute myocardial infarction patients reveal potential biomarkers for diagnosis, severity assessment, and treatment monitoring. , 2021, Glycobiology.

[7]  S. Kamphuis,et al.  Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response , 2021, Rheumatology.

[8]  G. Kazemier,et al.  CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity , 2021, Frontiers in Immunology.

[9]  A. Pandit,et al.  Therapies to prevent post-infarction remodelling: From repair to regeneration. , 2021, Biomaterials.

[10]  K. Schenke-Layland,et al.  Elastin-like hydrogel stimulates angiogenesis in a severe model of critical limb ischemia (CLI): An insight into the glyco-host response. , 2021, Biomaterials.

[11]  H. Jneid,et al.  Age-Stratified Sex-Related Differences in the Incidence, Management, and Outcomes of Acute Myocardial Infarction. , 2020, Mayo Clinic proceedings.

[12]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[13]  Marcel H. Schulz,et al.  Single cell sequencing reveals endothelial plasticity with transient mesenchymal activation after myocardial infarction , 2020, Nature Communications.

[14]  T. Russell,et al.  Myocardial infarction classification and its implications on measures of cardiovascular outcomes, quality, and racial/ethnic disparities , 2020, Clinical cardiology.

[15]  G. Corrao,et al.  Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes: Evidence from an Italian real-world investigation. , 2020, International journal of cardiology.

[16]  N. Karlsson,et al.  Identification by mass spectrometry and immunoblotting of xenogeneic antigens in the N- and O-glycomes of porcine, bovine and equine heart tissues , 2020, Glycoconjugate Journal.

[17]  Grazia Marsico.  Elastin-based hydrogel as a treatment for critical limb ischemia, an insight into the glyco-host response , 2019 .

[18]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[19]  L. Zentilin,et al.  MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs , 2019, Nature.

[20]  Fabio Bernini,et al.  MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs , 2019, Nature.

[21]  Richard P Harvey,et al.  Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury , 2019, eLife.

[22]  S. Neelamegham,et al.  Selectins and Immune Cells in Acute Myocardial Infarction and Post-infarction Ventricular Remodeling: Pathophysiology and Novel Treatments , 2019, Front. Immunol..

[23]  Xu Zhou,et al.  Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy , 2019, Nature Medicine.

[24]  N. Frangogiannis.  Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. , 2019, Molecular aspects of medicine.

[25]  A. Zaravinos,et al.  Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma. , 2019, Journal of proteomics.

[26]  L. Räber,et al.  Pre-existing treatment with aspirin or statins influences clinical presentation, infarct size and inflammation in patients with de novo acute coronary syndromes. , 2019, International journal of cardiology.

[27]  Jianyi(Jay) Zhang,et al.  Regenerative Potential of Neonatal Porcine Hearts , 2018, Circulation.

[28]  G. Corrao,et al.  Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation , 2018, Drugs & Aging.

[29]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[30]  J. Cipollo,et al.  The Glycoproteomics–MS for Studying Glycosylation in Cardiac Hypertrophy and Heart Failure , 2018, Proteomics. Clinical applications.

[31]  A. Munnich,et al.  SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects , 2018, Nature Communications.

[32]  Ashley C. Brown,et al.  Targeted Treatment of Ischemic and Fibrotic Complications of Myocardial Infarction Using a Dual-Delivery Microgel Therapeutic. , 2018, ACS nano.

[33]  Rongfeng Li,et al.  Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs. , 2018, Journal of biomedical research.

[34]  E. Olson,et al.  Therapeutic approaches for cardiac regeneration and repair , 2018, Nature Reviews Cardiology.

[35]  Rongfeng Li,et al.  Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH. , 2018, Acta biomaterialia.

[36]  P. Kaul,et al.  Impact of Type 2 Myocardial Infarction (MI) on Hospital‐Level MI Outcomes: Implications for Quality and Public Reporting , 2018, Journal of the American Heart Association.

[37]  C. Granger,et al.  Post-Myocardial Infarction Heart Failure. , 2018, JACC. Heart failure.

[38]  V. Pardo-Jiménez,et al.  Heparan sulfate potentiates leukocyte adhesion on cardiac fibroblast by enhancing Vcam-1 and Icam-1 expression. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[39]  Yiqing Tian,et al.  Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice , 2018, Scientific Reports.

[40]  Magdalena M. Zak,et al.  Deciphering microvascular changes after myocardial infarction through 3D fully automated image analysis , 2018, Scientific Reports.

[41]  J. Fawcett,et al.  Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling , 2018, Circulation.

[42]  Steven P Jones,et al.  Guidelines for experimental models of myocardial ischemia and infarction , 2018, American journal of physiology. Heart and circulatory physiology.

[43]  C. Torp-Pedersen,et al.  Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography: a historical cohort study , 2017, BMC Cardiovascular Disorders.

[44]  T. Cahill,et al.  Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics , 2017, Nature Reviews Drug Discovery.

[45]  W. Shimizu,et al.  Long-Term Outcomes of Non-ST-Elevation Myocardial Infarction Without Creatine Kinase Elevation　- The J-MINUET Study. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[46]  Erdmann Rapp,et al.  The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data , 2016, Glycobiology.

[47]  T. Henry,et al.  Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non–ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease , 2016, Circulation. Cardiovascular quality and outcomes.

[48]  M. Larsen,et al.  Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer. , 2016, Biochimica et biophysica acta.

[49]  F. Magni,et al.  Intraluminal proteome and peptidome of human urinary extracellular vesicles , 2015, Proteomics. Clinical applications.

[50]  M. Tector,et al.  Evaluation of human and non‐human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes , 2015, Xenotransplantation.

[51]  O. Ramilo,et al.  Abstract O.29: Transcriptional Profiling Discriminates Complete and Incomplete KD from Human Adenovirus , 2015 .

[52]  M. Neeman,et al.  ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation , 2015, Nature Cell Biology.

[53]  T. Fukui,et al.  Differential Time Trends of Outcomes and Costs of Care for Acute Myocardial Infarction Hospitalizations by ST Elevation and Type of Intervention in the United States, 2001–2011 , 2015, Journal of the American Heart Association.

[54]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[55]  S. Teneberg,et al.  Characterization of acid and non‐acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts , 2014, Xenotransplantation.

[56]  F. Harrell,et al.  Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure , 2014, Journal of the American Heart Association.

[57]  J. Pilla,et al.  Preclinical Evaluation of the Engineered Stem Cell Chemokine Stromal Cell–Derived Factor 1&agr; Analog in a Translational Ovine Myocardial Infarction Model , 2013, Circulation research.

[58]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[59]  M. Flather,et al.  Rates and causes of death from non-ST elevation acute coronary syndromes: ten year follow-up of the PRAIS-UK registry. , 2013, International journal of cardiology.

[60]  D. McManus,et al.  Survival after hospital discharge for ST-segment elevation and non-ST-segment elevation acute myocardial infarction: a population-based study , 2013, Clinical epidemiology.

[61]  P. Serruys,et al.  Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function , 2013, Circulation research.

[62]  Nicolle H. Packer,et al.  Structural Feature Ions for Distinguishing N- and O-Linked Glycan Isomers by LC-ESI-IT MS/MS , 2013, Journal of The American Society for Mass Spectrometry.

[63]  P. Armstrong,et al.  Incidence of heart failure and mortality after acute coronary syndromes. , 2013, American heart journal.

[64]  T. Potter,et al.  Reliability of quantitative echocardiography in adult sheep and goats , 2012, BMC Veterinary Research.

[65]  M. Funk,et al.  Left Ventricular Ejection Fraction Assessment Among Patients With Acute Myocardial Infarction and Its Association With Hospital Quality of Care and Evidence-Based Therapy Use , 2012, Circulation. Cardiovascular quality and outcomes.

[66]  G. Jayson,et al.  Endothelial Heparan Sulfate 6-O-Sulfation Levels Regulate Angiogenic Responses of Endothelial Cells to Fibroblast Growth Factor 2 and Vascular Endothelial Growth Factor* , 2012, The Journal of Biological Chemistry.

[67]  N. Packer,et al.  Structural analysis of N- and O-glycans released from glycoproteins , 2012, Nature Protocols.

[68]  U. Galili,et al.  Accelerated Porcine Wound Healing after Treatment with &agr;-Gal Nanoparticles , 2012, Plastic and reconstructive surgery.

[69]  P. Albanese,et al.  Age-related Changes in Rat Myocardium Involve Altered Capacities of Glycosaminoglycans to Potentiate Growth Factor Functions and Heparan Sulfate-altered Sulfation* , 2012, The Journal of Biological Chemistry.

[70]  Bin Ma,et al.  PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification* , 2011, Molecular & Cellular Proteomics.

[71]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[72]  J. Gorman,et al.  Targeted Regional Injection of Biocomposite Microspheres Alters Post–Myocardial Infarction Remodeling and Matrix Proteolytic Pathways , 2011, Circulation.

[73]  D. Greiner,et al.  Rapid Recruitment and Activation of Macrophages by Anti-Gal/α-Gal Liposome Interaction Accelerates Wound Healing , 2011, The Journal of Immunology.

[74]  Daniel Kolarich,et al.  Quantitative N-linked Glycoproteomics of Myocardial Ischemia and Reperfusion Injury Reveals Early Remodeling in the Extracellular Environment* , 2011, Molecular & Cellular Proteomics.

[75]  L. Cohn,et al.  A novel, innovative ovine model of chronic ischemic cardiomyopathy induced by multiple coronary ligations. , 2010, Artificial organs.

[76]  Robert C Gorman,et al.  Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model , 2010, Proceedings of the National Academy of Sciences.

[77]  Christian Mühlfeld,et al.  A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[78]  B. Yawn,et al.  Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction , 2010, Circulation.

[79]  Simon J North,et al.  Regulated and aberrant glycosylation modulate cardiac electrical signaling , 2009, Proceedings of the National Academy of Sciences.

[80]  R. Pérez,et al.  Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody1 , 2008, The Journal of Immunology.

[81]  R. Körfer,et al.  Transforming Growth Factor β1-regulated Xylosyltransferase I Activity in Human Cardiac Fibroblasts and Its Impact for Myocardial Remodeling* , 2007, Journal of Biological Chemistry.

[82]  F. Verheyen,et al.  Structural remodelling of cardiomyocytes in the border zone of infarcted rabbit heart , 2007, Molecular and Cellular Biochemistry.

[83]  E. W. Hancock,et al.  Recommendations for the standardization and interpretation of the electrocardiogram: part I: The electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Car , 2007, Circulation.

[84]  R. Gallo,et al.  Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  J. Courty,et al.  A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis* , 2005, Journal of Biological Chemistry.

[86]  J. Gardin,et al.  American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[87]  D. Papy-Garcia,et al.  Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. , 2003, Glycobiology.

[88]  Niclas G Karlsson,et al.  Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis. , 2002, Analytical chemistry.

[89]  T. Guy,et al.  An ovine model of postinfarction dilated cardiomyopathy. , 2002, The Annals of thoracic surgery.

[90]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[91]  A. Cohen-Solal,et al.  [Ventricular "remodeling" after myocardial infarction]. , 1991, Archives des maladies du coeur et des vaisseaux.

[92]  R. Asinger,et al.  Regional function and perfusion at the lateral border of ischemic myocardium. , 1985, Circulation.

[93]  OUP accepted manuscript , 2021, Glycobiology.

[94]  Bradley W Ellis,et al.  Distinct glycosylation in membrane proteins within neonatal versus adult myocardial tissue. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[95]  Weston Clive.  Myocardial Ischaemia National Audit Project - How the NHS cares for patients with heart attacks. Annual Public Report April 2014-March 2015 , 2017 .

[96]  R. Langer,et al.  Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF(165). , 2016, Biomaterials.

[97]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[98]  Adnan Halim,et al.  Advances in mass spectrometry driven O-glycoproteomics. , 2015, Biochimica et biophysica acta.

[99]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[100]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[101]  D. McManus,et al.  Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. , 2011, The American journal of medicine.

[102]  W. Grossman,et al.  Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. , 1988, Journal of the American College of Cardiology.